biguanides has been researched along with Heart Failure in 7 studies
Biguanides: Derivatives of biguanide (the structure formula HN(C(NH)NH2)2) that are primarily used as oral HYPOGLYCEMIC AGENTS for the treatment of DIABETES MELLITUS, TYPE 2 and PREDIABETES.
biguanides : A class of oral hypoglycemic drugs used for diabetes mellitus or prediabetes treatment. They have a structure based on the 2-carbamimidoylguanidine skeleton.
Heart Failure: A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Individuals with type 2 diabetes (T2DM) are at increased risk of cardiovascular disease, including heart failure (HF)." | 1.39 | Metformin treatment may be associated with decreased levels of NT-proBNP in patients with type 2 diabetes. ( Czlonkowski, A; Filipiak, KJ; Kaplon-Cieslicka, A; Opolski, G; Postula, M; Rosiak, M; Trzepla, E, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (71.43) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rosiak, M | 1 |
| Postula, M | 1 |
| Kaplon-Cieslicka, A | 1 |
| Trzepla, E | 1 |
| Czlonkowski, A | 1 |
| Filipiak, KJ | 1 |
| Opolski, G | 1 |
| Tanabe, M | 1 |
| Nomiyama, T | 1 |
| Motonaga, R | 1 |
| Murase, K | 1 |
| Yanase, T | 1 |
| SCHNEIDER, KW | 1 |
| PIPPIG, L | 1 |
| GATTENLOEHNER, W | 1 |
| Wittmann, P | 1 |
| Haslbeck, M | 1 |
| Bachmann, W | 1 |
| Mehnert, H | 1 |
| Poli, S | 1 |
| Vincent, A | 1 |
| Perret, C | 1 |
| Macmillan, AL | 1 |
| Ziegelasch, HJ | 1 |
1 review available for biguanides and Heart Failure
| Article | Year |
|---|---|
[Lactic acidosis].
Topics: Acidosis; Bicarbonates; Biguanides; Diabetes Mellitus; Epilepsy; Ethanol; Fructose; Heart Failure; H | 1985 |
6 other studies available for biguanides and Heart Failure
| Article | Year |
|---|---|
Metformin treatment may be associated with decreased levels of NT-proBNP in patients with type 2 diabetes.
Topics: Adrenergic beta-Antagonists; Aged; Atherosclerosis; Biguanides; Cardiovascular Diseases; Coronary Ar | 2013 |
Reduced vascular events in type 2 diabetes by biguanide relative to sulfonylurea: study in a Japanese Hospital Database.
Topics: Adult; Aged; Angina Pectoris; Biguanides; Cardiovascular Diseases; Cerebral Hemorrhage; Cerebral Inf | 2015 |
[THE EFFECT OF PREDNISONE BIGUANYLHYDRAZONE ON THE HEMODYNAMIC PARAMETER IN ACUTE EXPERIMENTS].
Topics: Biguanides; Blood Circulation Time; Blood Pressure; Blood Volume; Cardiac Output; Digitalis Glycosid | 1965 |
[Lactic acidosis in diabetics on biguanides (author's transl)].
Topics: Biguanides; Diabetic Ketoacidosis; Heart Failure; Humans; Hydrogen-Ion Concentration; Kidney Failure | 1977 |
Generalised pustular drug rash.
Topics: Adult; Aged; Biguanides; Chloramphenicol; Chloroquine; Cross Reactions; Digoxin; Drug Eruptions; Fur | 1973 |
[Extreme hypoglycemia during combined tolbutamide, n-1-butylbiguanide hydrochloride and chloramphenicol therapy].
Topics: Age Factors; Aged; Biguanides; Chloramphenicol; Diabetes Mellitus; Diabetic Angiopathies; Diabetic N | 1972 |